Sort by
Refine Your Search
-
by our motto of “CS for Everyone.” About the Opportunity The Khoury College of Computer Sciences seeks a Distinguished Research Fellow to establish and lead an independent research program. The
-
as an exhaustive list of all responsibilities, duties and skills required of personnel so classified. About the Opportunity: The Department of Psychology and Center for Cognitive and Brain Health
-
About the Opportunity Khoury College of Computer Sciences is looking for a Distinguished Research Fellow. Responsibilities: The Distinguished Research Fellow will be expected to start-up their own
-
candidates are strongly encouraged to indicate a member or members of the Mathematics Department with overlapping research interests. Application materials required: Cover letter Curriculum Vitae List
-
, United States of America [map ] Subject Area: Mathematics Appl Deadline: 2026/01/12 04:59 AM UnitedKingdomTime (posted 2025/12/16 05:00 AM UnitedKingdomTime, listed until 2026/06/17 04:59 AM UnitedKingdomTime) Position
-
development processes and organizational dynamics. Program Overview: Year 1: Foundational Training and Cross-Functional Immersion The Fellow will focus on building a strong foundation in scientific
-
the Institute for Mechanobiology (IfM) in Boston, MA (see https://mechanobiology.northeastern.edu/our-faculty for list of the IfM core faculty). This position has an initial 2-year appointment, renewable
-
consistently recognized as one of the industry's top places to work, including 15 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company
-
consistently recognized as one of the industry's top places to work, including 15 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company
-
. About Eidos and BridgeBio Pharma Inc. BridgeBio Pharma, Inc. (BridgeBio/BBIO) is a biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who